2
Registered trials
1
Recruiting
2
Unique sponsors
1
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase II:
1
Phase I:
1
Phase II
1 trial-
EndedBoehringer Ingelheim International GmbH Commercial(3S,3'S,3A'S,10A'S)-6-CHLORO-3'-(3-CHLORO-2-FLUOROPHENYL)-1'-(CYCLOPROPYLMETHYL)-6'-METHYL-2-OXO-1,2,3',3A',10',10A'-HEXAHYDRO-1'H-SPIRO[INDOLE-3,2'-PYRROLO[2',3':4,5]PYRROLO[1,2-B]INDAZOLE]-7'-CARBOXYLIC ACID
Phase I
1 trial-
RecruitingBeOne Medicines AG CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| BeOne Medicines AG | Commercial | 1 | Phase I | 1 |
| Boehringer Ingelheim International GmbH | Commercial | 1 | Phase II | 0 |
New trials by year
2022
1
2024
1